ABMC - American Bio Medica Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.1718
+0.0068 (+4.12%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.1650
Open0.1720
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1606 - 0.1720
52 Week Range0.0600 - 0.4400
Volume191,741
Avg. Volume707,325
Market Cap5.615M
Beta (5Y Monthly)-1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.0270
Earnings DateMay 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    ABMC Offers Rapid Test for Covid-19

    KINDERHOOK, NY / ACCESSWIRE / March 23, 2020 / American Bio Medica Corporation (OTC PINK:ABMC), a manufacturer of accurate, cost-effective immunoassay test kits, announced today that it began offering on March 17, 2020, via a distribution partnership, a Rapid Test to detect Covid-19 in whole blood, serum or plasma. The test has not yet been reviewed by the U.S. Food and Drug Administration (FDA), but is being offered under the March 16, 2020 guidance set forth by the FDA. To place an order, customers can call (800) 227-2343, or (518) 758-8158 outside the United States or, contact the company via email at COVID19@abmc.com.

  • ACCESSWIRE

    ABMC Reports Third Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / November 14, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the three and nine months ended September 30, 2019. Chief Executive ...

  • ACCESSWIRE

    ABMC Reports Second Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / August 14, 2019 / American Bio Medica Corporation ( OTC PINK:ABMC ) today announced financial results for the three and six months ended June 30, 2019. Chief Executive Officer ...